These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 24363103)

  • 1. Treatment of restless legs syndrome.
    Comella CL
    Neurotherapeutics; 2014 Jan; 11(1):177-87. PubMed ID: 24363103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
    Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
    Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of restless legs syndrome in patients on dialysis.
    Molnar MZ; Novak M; Mucsi I
    Drugs; 2006; 66(5):607-24. PubMed ID: 16620140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment options for restless legs syndrome.
    Wetter TC; Winkelmann J; Eisensehr I
    Expert Opin Pharmacother; 2003 Oct; 4(10):1727-38. PubMed ID: 14521483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.
    Garcia-Borreguero D; Kohnen R; Silber MH; Winkelman JW; Earley CJ; Högl B; Manconi M; Montplaisir J; Inoue Y; Allen RP
    Sleep Med; 2013 Jul; 14(7):675-84. PubMed ID: 23859128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restless legs syndrome: treatment with dopaminergic agents.
    Comella CL
    Neurology; 2002 Feb; 58(4 Suppl 1):S87-92. PubMed ID: 11909990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis.
    Iftikhar IH; Alghothani L; Trotti LM
    Eur J Neurol; 2017 Dec; 24(12):1446-1456. PubMed ID: 28888061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for restless legs syndrome.
    Ferini-Strambi L; Marelli S
    Expert Opin Pharmacother; 2014 Jun; 15(8):1127-38. PubMed ID: 24745717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
    Geyer J; Bogan R
    Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.
    Sun Y; van Valkenhoef G; Morel T
    Curr Med Res Opin; 2014 Nov; 30(11):2267-78. PubMed ID: 25050588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review.
    Safarpour Y; Vaziri ND; Jabbari B
    Tremor Other Hyperkinet Mov (N Y); 2023; 13():10. PubMed ID: 37008995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADMET considerations for restless leg syndrome drug treatments.
    de Biase S; Merlino G; Lorenzut S; Valente M; Gigli GL
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1247-61. PubMed ID: 22808933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restless legs syndrome-current therapies and management of augmentation.
    Trenkwalder C; Winkelmann J; Inoue Y; Paulus W
    Nat Rev Neurol; 2015 Aug; 11(8):434-45. PubMed ID: 26215616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restless legs syndrome in the older adult: diagnosis and management.
    Milligan SA; Chesson AL
    Drugs Aging; 2002; 19(10):741-51. PubMed ID: 12390051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Restless legs syndrome: diagnosis and treatment. Opinion of Brazilian experts].
    Arq Neuropsiquiatr; 2007 Sep; 65(3A):721-7. PubMed ID: 17876423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating Severe Refractory and Augmented Restless Legs Syndrome.
    Winkelman JW
    Chest; 2022 Sep; 162(3):693-700. PubMed ID: 35609673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome.
    Oertel WH; Trenkwalder C; Zucconi M; Benes H; Borreguero DG; Bassetti C; Partinen M; Ferini-Strambi L; Stiasny-Kolster K
    Mov Disord; 2007; 22 Suppl 18():S466-75. PubMed ID: 17516455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of restless legs syndrome].
    Haba-Rubio J; Krieger J
    Presse Med; 2010 May; 39(5):571-8. PubMed ID: 20303704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Winkelman JW; Armstrong MJ; Allen RP; Chaudhuri KR; Ondo W; Trenkwalder C; Zee PC; Gronseth GS; Gloss D; Zesiewicz T
    Neurology; 2016 Dec; 87(24):2585-2593. PubMed ID: 27856776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.